Consumer Defensive
Dabur India Limited (NSE: DABUR) gains 5% intraday
Dabur India Limited (NSE: DABUR) stock price gains 5% intraday to ₹443.9, showing a trendline breakdown. Despite the rise, it has not cleared 6M resistance.
Dabur India Limited (DABUR) breaks out with a +5% gain to ₹443.9 on the NSE today, clearing its 6M resistance trendline. This move is driven by technical factors, specifically the stock’s breakout above the ₹416 resistance level. Dabur, a major player in the consumer defensive sector under household and personal products, has seen this move despite a generally sluggish sector performance, indicating a company-specific catalyst rather than broad-based sector momentum.
Technical setup — trendlines & DMA
From a technical standpoint, DABUR’s current price is comfortably above the 6M support trendline at ₹403.75, sitting 9.04% higher, and has decisively cleared the 6M resistance trendline at ₹415.81 by 6.33%. However, the stock is still trading below both its 50-DMA at ₹443.0 and the 200-DMA at ₹480.4, indicating a bearish trend. Within its 52-week range of ₹403.4 to ₹577.0, the current price is in the lower third, suggesting that while there’s room for further upside, a significant portion of potential gains may already be priced in.
Snapshot: ₹443.90 on 2026-07-01 (chart frozen at publication)
Fundamentals & business context
Fundamentally, DABUR’s PE of 39.6 appears stretched given its profit margin of 14.4% and a revenue CAGR of 4.9%. This suggests that the market may be pricing in future growth or a turnaround that the current earnings do not yet support. Institutional ownership stands at 23.2%, indicating a cautious yet positive view from the smart money. There’s no NSE catalyst today, reinforcing that today’s move is technical rather than driven by new fundamental information.
Algorithmic scorecard
The overall algorithmic scorecard reflects a balanced but cautious view of DABUR, with a slight lean towards fundamental strength despite technical weaknesses. Two of the strongest signals are the company’s perfect record of consistent revenue growth every year, showcasing exceptional business stability, and its very low debt levels with a D/E of 0.00, indicating excellent financial health. On the flip side, the stock’s overvalued status with a PEG of 11.31 and its low dividend yield of 1.94% are significant risks. The overvalued PEG suggests that the stock price may not be justified by its growth rate, while the low dividend yield offers minimal income contribution to investors.
Company outlook
Dabur’s management has outlined an optimistic forward guidance, revising revenue growth expectations to high single to low double-digit growth, driven by a combination of pricing and volume increases. They anticipate sequential improvement in margins year-on-year, supported by premiumization, pricing strategies, and various initiatives. The international business is expected to grow in double digits, despite a decline in volume, thanks to pricing increases and translation gains from rupee depreciation. For the India business, margins are planned to be maintained at least in Q1 through price increases, reducing grammage, and optimizing trade and CP spend. New product launches and variants are in the pipeline to drive premiumization and mitigate inflationary pressures.
Get all details on DABUR — P&L, peers, shareholding and more on TradeAlone.
Consumer Defensive
Piccadily Agro Industries Limited (piccadil) Q2 FY27: Distillery Revenue Grows 30.5% YOY
Piccadily Agro Industries Ltd. reports a 30.5% YOY growth in distillery revenue for Q2 FY27, driven by premium spirits.
Piccadily Agro Industries Limited (PAIL), one of India’s leading producers of premium alcoholic beverages, announced its financial results for the quarter ended September 30, 2026. The Company reported a revenue from operations of INR 277.9 crore in Q2 FY27, up 19.4% YoY from INR 232.7 crore in the corresponding quarter last year, driven by continued momentum in its Distillery business. Distillery revenue increased 30.5% YoY to INR 271.3 crore and accounted for 97.6% of the Company’s quarterly revenue, compared with 89.3% in Q2 FY26.
Distillery Performance
The Distillery business remains the principal growth engine, with its increasing contribution reflecting the progress made in strengthening Piccadily’s spirits-led business. The scaling up of the Chhattisgarh Distillery, together with enhanced manufacturing capabilities, positions the company well to support long-term growth ambitions.
Product Innovation and Expansion
The Company continues to advance its strategic focus on strengthening its premium, super-premium, and luxury spirits portfolio, expanding market presence and distribution, enhancing brand equity, and leveraging its expanded manufacturing capabilities to drive sustainable long-term growth. Recent product introductions, including Indri Ilika, Indri Agneya, and the Diwali Collector’s Edition 2026, further reinforce the depth and premium positioning of its portfolio.
Future Outlook
Commenting on the results, Mr. Natwar Agarwal, Chief Financial Officer, Piccadily Agro Industries Limited, said, “Q2 FY27 saw continued momentum in our core Distillery business, which grew over 30% YoY, while overall Company revenue increased by 19.4%. Our H1 FY27 PAT is higher than the corresponding period last year, reflecting the underlying strength of our business and continued progress towards our financial objectives. The Company remains firmly on track to achieve its business objectives, with a continued focus on building differentiated brands, expanding its distribution footprint, strengthening manufacturing capabilities, and deepening its presence across domestic and international markets.”
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of Piccadily Agro Industries Limited
Piccadily Agro Industries Limited belongs to the Consumer Defensive › Beverages – Wineries & Distilleries sector. Here’s a quick read on where the business and the stock stand today.
Piccadily moves sideways over three months, with neither buyers nor sellers taking control. The PEG of 0.49 is extremely low. Either the market misses the growth story, or there is a catch worth investigating. The business compounds revenue at 19.5% and profits at 83.3% CAGR. That is strong double-digit growth on both counts. The stock gains 3.6% in the last month, recovering from the three-month slide. However, it is too early to call this a confirmed reversal. Revenue grows at 19.5% and profits at 83.3% CAGR, with D/E of 0.00. Meanwhile, the stock dips 7.7% in three months without any fundamental deterioration. Consequently, the stock quietly becomes cheaper relative to earnings power. For long-term investors, that is a feature. Check Fundamentals of Piccadily Agro Industries Limited.
Consumer Defensive
Procter & Gamble Hygiene and Health Care Ltd. Q2 FY27: Sales Flat, PAT Down 7%
Procter & Gamble Hygiene and Health Care Ltd. (PGHH) reports flat sales and a 7% drop in PAT for Q2 FY27, driven by cost fluctuations.
Procter & Gamble Hygiene and Health Care Ltd. (PGHH) today announced its financial results for the second quarter ended September 30, 2026. The company reported sales of ₹ 1145 crores, flat versus the same quarter last year. Profit After Tax (PAT) was reported at ₹196 crores, down 7% versus the same period last year.
Impact of Cost Fluctuations
In the quarter, the company experienced a double-digit impact on profitability driven by commodity cost fluctuations and headwinds like raw material and energy costs, as well as unfavorable foreign exchange rates. However, a significant portion of this was offset by the robust productivity program.
Strategic Investments
In the quarter, the company also continued to significantly invest back in innovation and advertising & promotion (versus past quarter) – in an endeavor to position the company for long-term competitiveness and value creation.
Kumar Venkatasubramanian, Managing Director, Procter & Gamble Hygiene and Health Care Ltd. said, “We continue to invest strategically in our brands, innovation and market capabilities, even as the macro-economic landscape remains challenging. We continue to believe that our strategic priorities, combined with the strength of our brands and organizational capabilities, position us well to leverage future growth opportunities and create sustainable long-term value for all our stakeholders. We are excited about the future.”
The first half of FY 2026–27 was marked by sustained innovation across our vectors of superiority. Key milestones include the launches of the upgraded Vicks ZzzQuil with Ashwagandha and Vicks medicated lozenges, alongside the ongoing evolution of our media model to better engage consumers where they are. The Company continues to focus on, and drive, Whisper Period Pants to delight consumers with 360-degree leakage protection.
As we look ahead, we remain committed to our Integrated Growth Strategy, focusing on a focused product portfolio of daily use categories where performance drives brand choice, superiority, productivity, constructive disruption, and an agile and accountable organization to deliver balanced growth and value creation.
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of Procter & Gamble Hygiene and Health Care Limited
Procter & Gamble Hygiene and Health Care Limited belongs to the Consumer Defensive › Household & Personal Products sector. Here’s a quick read on where the business and the stock stand today.
Procter drops 15.1% over three months and trades near its 52-week lows. D/E sits at 0.00 with a 3.22% dividend and unbroken revenue growth. Financial stability is a genuine strength. The PEG of 2.08 is on the high side. However, it is acceptable for a quality compounder with a strong moat. Sellers drive 2.6x the volume of buyers. Furthermore, they controlled 18 of recent sessions versus 12 for buyers — a clear distribution signal. The business compounds at 4.1% revenue and 14.2% profit CAGR, with D/E of 0.00. Yet the stock drops 15.1% in three months. The business does not deteriorate — the stock does. That gap is what long-term investors look for. Check Fundamentals of Procter & Gamble Hygiene and Health Care Limited.
Consumer Defensive
Cupid Limited (NSE: Cupid) Q2 FY27: Net Profit Growth of 133% Yoy; H1 FY27 Net Profit Rises 156% Yoy to ₹100.37 Crore
Cupid Limited (NSE: CUPID) reports Q2 FY27 net profit growth of 133% YoY and H1 FY27 net profit rises 156% to ₹100.37 crore.
Cupid Limited (NSE: CUPID), a leading consumer wellness and personal care company, announced its unaudited financial results for the quarter and half year ended 30th September, 2026. The company reported a net profit growth of 133% YoY for Q2 FY27 and a net profit rise of 156% YoY to ₹100.37 crore for H1 FY27. The total income for Q2 FY27 stood at ₹208.97 crore, marking a 132% YoY increase. Moreover, H1 FY27 total income grew 136% to ₹365.95 crore. Cupid Limited has raised its FY27 guidance to ₹880+ crore revenue and ₹275+ crore net profit.
Q2 FY27 Financial Highlights
Cupid Limited’s Q2 FY27 total income was ₹208.97 crore, up 132% YoY. The operating income was ₹187.86 crore, showing a 122% YoY increase. The net profit for the quarter was ₹56.22 crore, reflecting a 133% YoY growth. The EBITDA margin was 29%.
H1 FY27 Financial Highlights
For H1 FY27, the total income increased to ₹365.95 crore, growing 136% YoY. The net profit for the half year was ₹100.37 crore, up 156% YoY. The EBITDA stood at ₹114.83 crore, marking a 156% YoY increase. The company continues to focus on strengthening its product mix, sourcing efficiencies, and scale benefits as its Consumer Healthcare & FMCG business expands across organized retail channels.
Future Outlook
Cupid Limited anticipates H2 FY27 to be significantly stronger due to the commissioning of the Palava facility in Q3 FY27 and the expansion of its retail partnerships. The company expects to add manufacturing capacity and enhance its presence in organized retail, which will likely drive higher volumes in the second half of the fiscal year. Cupid Limited has also raised its guidance for FY28 and FY29, projecting revenues of ₹1,305+ crore and ₹1,950+ crore, respectively, with corresponding net profits of ₹390 crore and ₹605 crore.
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of Cupid Limited
Cupid Limited belongs to the Consumer Defensive › Household & Personal Products sector. Here’s a quick read on where the business and the stock stand today.
Cupid gains 20.1% over three months and trades near its 52-week highs. The PEG stands at 6.97 — severely stretched. Any earnings miss could trigger a sharp de-rating. Industry-leading margins of 30.4% reflect exceptional pricing power and operational efficiency. The stock gives back 2.2% in the last month despite a positive three-month run. As a result, the earlier momentum appears to be fading. The stock rises 20.1% in three months on 31.2% revenue growth. As a result, the market gives it more credit than the fundamentals strictly justify. Watch the next quarterly results. If growth accelerates, the move makes sense. If not, expect some gains to unwind. Check Fundamentals of Cupid Limited.
-
Consumer Defensive3 days agoCupid Limited (NSE: Cupid) Q2 FY27: Net Profit Growth of 133% Yoy; H1 FY27 Net Profit Rises 156% Yoy to ₹100.37 Crore
-
ADANIENT3 days agoAdani Enterprises Limited (adanient) Kutch Copper First Indian Producer to Receive Veramark Assurance Certification
-
Information Technology Services2 days agoLtm Limited (LTM) Introduces Ai-powered Quantum Error Mitigation to IBM Quantum Functions Catalog
-
ECLERX2 days agoEclerx Services Limited (eclerx) Announces Acquisition of Regedge
-
TATAPOWER3 days agoTata Power Delivers Highest-ever Quarterly Profit (tatapower) Q2 FY27: PAT Up 33% Yoy
-
RATEGAIN2 days agoRategain Travel Technologies Limited (NSE: Rategain) Partners with Uzbekistan Airways to Enhance Pricing Agility
-
Consumer Cyclical3 days agoPopular Vehicles and Services Limited Q2 & H1 FY27: Revenue Up 57% Yoy, Service Growth Strong
-
AYE3 days agoAye Finance Limited (AYE) Receives ICRA Upgrade to A+ (stable Outlook)